Gelesis takes in $31.5 mln

By Iris Dorbian — 2 months ago

Gelesis, a biotech company focused on developing products that promote weight loss and improve glycemic control, has raised $31.5 million in funding. The investors included Cormorant Asset Management, Invesco Asset Management, PureTech and the Priztker/Vlock family office.


SciFluor Life Sciences garners $30 mln

By Iris Dorbian — 10 months ago

Cambridge, Massachusetts-based drug discovery company SciFluor Life Sciences, a subsidiary of Allied Minds, has secured $30 million in funding. The investors included Invesco Asset Management, Woodford Investment Management and parent company Allied Minds. Also, the company has appointed Dr. William Koster as chairman of the board.


Spin Transfer Tech Nabs Huge A Round

By Jonathan Marino — 4 years ago

Boston-based Spin Transfer Technologies, the developer of computer memory technology, secured a $36 million Series A round. The investment was led by Spin Transfer Tech’s parent company, Allied Minds and Invesco Asset Management. Spin Transfer Tech was established by NYU and Allied Minds. PRESS RELEASE BOSTON–(BUSINESS WIRE)–Spin Transfer Technologies, Inc. a leading developer of a […]